Johnson & Johnson

Equities

JNJ

US4781601046

Pharmaceuticals

Market Closed - Nyse 04:00:02 2024-04-15 pm EDT 5-day change 1st Jan Change
147.6 USD +0.05% Intraday chart for Johnson & Johnson -2.64% -5.84%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
MORNING BID EUROPE-Market mood stays sombre RE
MEDIA-Zimbabwe recalls tainted J&J's cough syrup sold in six African nations- Bloomberg News RE
Tanzania, Rwanda Latest to Recall Batch of Johnson & Johnson's Infant Cough Syrup MT
Global markets live: Goldman Sachs, Apple, Salesforce, Boeing Tesla... Our Logo
Integer Holdings to Benefit from Pulsed Field Ablation Market Growth, BofA Says MT
Market outlook is uncertain, but optimism prevails Our Logo
Rwanda joins other African countries in recalling J&J children's cough syrup RE
US Equity Investors to Focus on Quarterly Earnings This Week as Geopolitical Risks Look Contained Despite Iran Attack MT
Equity Futures Gain Pre-Bell Ahead of Busy Earnings Week; Asia Down, Europe Rises MT
S&P 500 Posts Second Consecutive Weekly Drop Led by Financials Amid Higher-Than-Expected Consumer Prices MT
US Equity Markets Close Mixed After March Producer Price Inflation Data MT
Sector Update: Health Care Stocks Softer Late Afternoon MT
Kenya recalls J&J children's cough syrup over suspected toxicity RE
Top Midday Gainers MT
J&J: presents results on nipocalimab CF
Kenya recalls J&J children's cough syrup over suspected toxicity RE
Exchange-Traded Funds, Equity Futures Lower Pre-Bell Thursday Ahead of Another Key Inflation Report MT
Johnson & Johnson Announces Planned Presentation of New Non-Clinical Studies CI
Rallybio Corporation Announces Collaboration with Johnson & Johnson CI
Nigeria recalls J&J children's cough syrup over toxic substance RE
Morgan Stanley Trims Price Target on Johnson & Johnson to $168 From $169, Keeps Equalweight Rating MT
J&J: presents results on anticoagulant CF
Sector Update: Health Care Stocks Flat to Higher Premarket Monday MT
Global markets live: Boeing, Shell, AstraZeneca, Tesla, Meta... Our Logo
Johnson & Johnson, Legend Biotech's Carvykti Receives FDA Approval to Treat Relapsed, Refractory Multiple Myeloma MT
Chart Johnson & Johnson
More charts
Johnson & Johnson is one of the world's leading producers of healthcare products. Net sales break down by family of products as follows: - pharmaceutical products (55.4%): drugs intended for the treatment of cardiovascular diseases, oncological diseases, gastro-intestinal illnesses, infectious, immunological, neurological, dermatological diseases, etc.; - medical products and equipment (28.9%): diagnostic systems, orthopedic and gynecological equipment, surgical materials, etc. for use by healthcare professionals; - consumer health products (15.7%): OTC drugs (Tylenol, Sudafed, Benadryl, Zyrtec, Motrin, Nicorette and other brands), health and beauty products (Aveeno, Clean & Clear, Dr. CI:Labo, Neutrogena and OGX), baby care products (Johnson's and Aveeno Baby), oral care products (Listerine), feminine hygiene products (Stayfree and Carefree and o.b.), wound care products (Band-Aid and Neosporin) etc. At the end of 2022, Johnson & Johnson has 89 manufacturing facilities located in the United States (28), North America (9), Europe (27), Africa and Asia/Pacific (25). Net sales are distributed geographically as follows: the United States (51.2%), Europe (24.7%), Asia/Pacific and Africa (17.7%) and other (6.4%).
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
22
Last Close Price
147.6 USD
Average target price
175.4 USD
Spread / Average Target
+18.82%
Consensus
  1. Stock Market
  2. Equities
  3. JNJ Stock
  4. News Johnson & Johnson
  5. Johnson & Johnson's Janssen Receives EU Medicines Agency Panel's Backing for Leukemia Drug